This clinical trial was a double-blind, randomized study involving elective surgery candidates undergoing general anesthesia with LMA placement. The study was conducted from 2021 to 2022 at Faiz Hospital, affiliated with Isfahan University of Medical Sciences. The study was approved by the Research Ethics Committee of Isfahan University of Medical Sciences (code:
IR.MUI.MED.REC.1400.074); it was also registered in the Iranian Registry of Clinical Trials (code:
IRCT20200217046523N15).
3.2. Exclusion Criteria
Patients meeting any of the following criteria were excluded from the study: Mouth opening less than 25 mm, Malampati grade above 2, requiring more than 2 attempts to insert LMA, limited neck extension, cervical spine abnormalities, pregnancy, supra-glottic anatomical abnormalities, surgery duration exceeding 2 h, risk of aspiration, need for oral and nasal surgery, and presence of sore throat and dysphagia. The sample size was determined based on the sample size formula of 45 patients in each group with a significance level of 5% (Z1-α/2 = 1.96) and statistical power of 80% (Z1-β = 0.84). To detect a standardized effect size of D = 0.60 and to account for patient attrition during the follow-up period, we included 55 patients in each group.
This investigation was conducted in a double-blind manner, with both the patient and anesthesiologist (who was responsible for recording the data) being uninformed about the laryngeal mask insertion technique. Additionally, the 4th-year anesthesiology resident responsible for placing the laryngeal mask did not participate in data collection.
Randomization of the study was achieved using random numbers generated by the Random Allocation software and sealed envelope technique, assigning participants to one of the 2 following groups: Group A (classic method) and group B (FFTMT).
This clinical study was conducted after obtaining permission from the Medical Ethics Committee of Isfahan University of Medical Sciences, with the researcher present in the operating room. A total of 110 patients were assessed for eligibility, but 10 were found to be ineligible because they did not meet the inclusion criteria. Therefore, the study included 100 participants. Subsequently, using randomization software, patients were randomly divided into 2 groups: Classic (50 subjects) and FFTMT (50 subjects) groups. In the classic group, 5 patients were excluded from the study due to the need for more than 2 attempts for LMA insertion, resulting in an analysis being performed on 95 patients.
After obtaining informed consent from all study participants, meticulous records were collected, including demographic and clinical information. Upon admission to the operating room, intraoperative monitoring was conducted, including continuous electrocardiogram (ECG), noninvasive blood pressure (NIBP), oxygen saturation (SpO2), end-tidal CO2 (EtCO2), and airway pressure. Following preoxygenation, anesthesia was induced through the administration of intravenous fentanyl at 2 μg/kg, propofol at 2 mg/kg, and atracurium at 0.3 mg/kg. In the elderly (over 65 years old), the dose of propofol for induction of anesthesia was reduced by 20%.
Patients were ventilated with oxygen via a face mask for 2 min. Then, an experienced 4th-year anesthesiology resident, proficient in both methods of LMA placement, inserted the LMA. Anesthesia was maintained through the administration of isoflurane in oxygen, along with atracurium (initially at a dose of 0.3 mg/kg, followed by 0.1 mg/kg every 30 min). Mechanical ventilation was performed using a volume-controlled and time-cycled method, with a tidal volume set between 5 - 8 mL/kg to ensure that peak inspiratory pressure remained below 20 cm of H2O. The frequency of the ventilator was adjusted to maintain EtCO2 levels between 35- and 40-mm Hg, with an inspiratory to expiratory ratio of 1: 2.
Hemodynamic parameters were measured and recorded at baseline (T1) and 1, 3, 5, and 10 min (T2 - T4) after LMA installation. The selection of the LMA size was based on the patient’s body weight, with size 3 chosen for weights less than 50 kg, size 4 for weights between 50 - 70 kg, and size 5 for weights over 70 kg (
13,
14). The sniffing position (neck flexion by head elevation and head extension) is commonly used for the insertion of LMA (
15).
In the classic method of LMA insertion, the posterior aspect of the cuff was coated with a water-based lubricant. The LMA tube was then grasped between the thumb and index finger of the dominant hand while the nondominant hand extended the patient’s head. The index finger was used to press the tip of the cuff against the hard palate, while the middle finger opened the patient’s mouth. A gradual inward motion was applied, followed by forward advancement of the LMA until encountering some resistance. Finally, the LMA was lowered with the nondominant hand, and the cuff was inflated to the lowest possible volume required to achieve a pressure of 40 - 60 cm H2O.
In the FFTMT insertion group, the anesthesiologist stood next to the patient (face-to-face), and the laryngeal mask was inserted, as described below.
The palmar surface of the second and third fingers of the nondominant hand was pushed forward from the surface of the tongue as far as possible. Then, the Head Tilt-Chin Lift and Jaw Thrust maneuvers were performed (
Figure 1). In the next step, using the dominant hand, the lubricated cuff of the laryngeal mask was placed on the fingers and pushed forward until it was in the correct position. Afterward, while holding the LMA with the dominant hand, the fingers of the nondominant hand were removed from the patient’s mouth, and the head position was returned to normal. The LMA cuff was inflated to a pressure of 40 - 60 cm H
2O, and the LMA was fixed in place.
The laryngeal mask airway placement in face-to-face triple maneuvers (face-to-face triple maneuver technique) (A, B, C)
To ensure the correct placement of the LMA in both procedures, positive pressure ventilation was performed simultaneously with capnography and auscultation.
In this study, an anesthesiologist, who was not part of the research team, assessed and recorded data such as the number of attempts to insert the mask, insertion time (from the moment the anesthesiologist held the mask until viewing the capnograph), the success rate at the first attempt, and the occurrence of adverse events, such as hypoxia, hemodynamic disturbances, presence of blood on the cuff, hoarseness, sore throat, and laryngospasm.
Criteria for successful LMA placement:
1. Establishing a stable airway.
2. Rising of the laryngeal mask when inflating the cuff.
3. The prominence of the anterior part of the neck at the same time as the inflation of the cuff.
4. Placing the laryngeal mask in the central line so that the black line on the posterior surface of the LMA tube is positioned in the central line and aligns with the level of the upper incisors (
6).
Criteria for successful ventilation:
1. Achieving sufficient chest expansion.
2. Maintaining stable oxygenation.
3. Displaying square capnography curves.
4. Attaining a minimum tidal volume of 7 mL/kg (
6).
If all 4 of the above criteria were met, the ventilation was considered optimal. If any of the above criteria were not met, the ventilation was considered suboptimal.